期刊文献+

肝细胞癌中Nodal的表达及其与血管生成和上皮间质转化的关系 被引量:3

Expression of Nodal in hepatocellular carcinoma and its relationship with angiogenesis and epithelial-mesenchymal transition
原文传递
导出
摘要 目的 探讨Nodal在肝细胞癌中表达情况,及其与血管生成和上皮间质转化(EMT)的关系.方法 2006年9月到2010年6月,收集16例冷冻肝癌组织和癌旁组织,应用实时荧光定量PCR(qPCR)和Western blot检测Nodal的表达;收集10例正常肝组织、96例肝癌组织和癌旁组织,采用免疫组化染色检测Nodal的表达,分析Nodal表达与肝癌临床病理特征及生存预后之间的关系.同时分析96例肝细胞癌患者癌组织Nodal、CD34和Vimentin的表达,探讨Nodal的表达与血管生成、EMT间的关系.结果 免疫组化染色显示Nodal主要在细胞质中表达.肝癌组织中高表达Nodal的比率为72.9% (70/96),显著高于癌旁组织(8.3%)和正常组织(0) (x2 =83.001、24.470,P<0.001).qPCR和Western blot检测结果显示,肝癌组织中Nodal表达水平明显高于癌旁组织和正常肝组织(P<0.05).Nodal高表达与肿瘤最大径(x2=15.318,P=0.000)、甲胎蛋白(x2=3.850,P=0.049)、吲哚氰绿15 min潴留率(x2=6.590,P=0.010)和侵袭转移(x2=17.824,P =0.000)有关.免疫组化染色检查发现,肝癌组织中Nodal的表达与微血管密度(MVD)有关(t=3.070,P=0.006),与Vimentin的表达无关(r=0.198,P=0.053).生存分析发现,高表达Nodal的患者术后积累生存率明显小于低表达者(x2 =487.053,P<0.001).多因素分析表明,Nodal高表达是影响肝癌患者术后生存的独立危险因素(RR =2.757,95% CI:1.450~5.240,P=0.002).结论 Nodal不参与肝癌EMT,但可促进肝癌血管形成,可作为判断肝癌患者生存预后的指标之一. Objective To detect the expression of Nodal in hepatocellular carcinoma (HCC),and explore its relationship with angiogenesis and epithelial-mesenchymal transition (EMT).Methods From September 2006 to June 2010,the 16 self-paired frozen HCC specimens were collected and the expression of Nodal was detected by qPCR and Western blot.The 10 normal liver tissues and 96 cases of HCC tumor and paracarcinomatous tissues were collected.The expression of Nodal and relationship among Nodal,clinicopathological characteristics of HCC and patients' prognosis were detected and analyzed using immunohistochemistry.The expressions of Nodal,Vimentin and CD34 in 96 HCC tumor tissues were detected by immunohistochemistry,and then judgment relationship between the expression of Nodal,EMT and angiogenesis.Results Immunohistochemistry showed that Nodal mainly expressed in the cytoplasm.The high expression rate of Nodal in HCC tumor tissues was 72.9% (70/96),which was remarkably higher than that in paracarcinomatous tissues (8.3%) and normal liver tissues (0) (x2 =83.001 and 24.470,both P〈0.001).qPCR and Western blot analysis showed that the expression level of Nodal in HCC was significantly higher than that in paracarcinomatous and normal tissues (P 〈 0.05).The high expression of Nodal in HCC was correlated with tumor size (x2 =15.318,P =0.000),alpha-fetoprotein (x2 =3.850,P =0.049),indocyanine green retention rate at 15 minutes (x2 =6.590,P =0.010),and invasion and metastasis (x2 =17.824,P =0.000).High expression of Nodal was positively correlated with high microvascular density in HCC (t =3.070,P =0.006),but not with Vimentin (r =0.198,P =0.053).Survival analysis showed that accumulated survival rate of patients with high expression of Nodal was significantly less than that the low expression (x2 =487.053,P 〈 0.001).The Cox multivariate analysis demonstrated that high expression of Nodal was independent risk factors for cumulative survival in patients with hepatocellular carcinoma after a curative resection (RR =2.757,95% CI:1.450-5.240,P =0.002).Conclusions Nodal does not participate in EMT of HCC,but can promote angiogenesis,and it could be used as a predictor of poor prognosis.
出处 《中华外科杂志》 CAS CSCD 北大核心 2014年第3期188-192,共5页 Chinese Journal of Surgery
基金 国家自然科学基金资助项目(81272398) 安徽省科技攻关资助项目(12010402112) 安徽省自然科学基金资助项目(1208085MH133) 安徽省高校自然科学研究资助项目(KJ2012Z179)
关键词 肝细胞 转化生长因子Β 新生血管化 病理性 因素分析 统计学 Carcinoma,hepatocellular Transforming growth factor beta Neovascularization,pathologic Factor analysis,statistical
作者简介 通信作者:李建生,Email:lijiansheng1953@163.com
  • 相关文献

参考文献25

  • 1Conlon FL, Lyons KM, Takaesu N, et al. A primary requirement for nodal in the formation and maintenance of the primitive streak in the mouse [J]. Development, 1994, 120 (7): 1919-1928.
  • 2Shen MM. Nodal signaling: developmental roles and regulation [J]. Development, 2007, 134 (6): 1023-1034.
  • 3Schier AF. Nodal morphogens [ J ]. Cold Spring Harb Perspect Biol, 2009, 1 (5): a003459.
  • 4Hendrix M J, Seftor EA, Seftor RE, et al. Reprogramming metastatic tumour cells with embryonic microenvironments [ J ]. Nat Rev Cancer, 2007, 7 (4) : 246-255.
  • 5Schier AF, Shen MM. Nodal signalling in vertebrate development [J]. Nature, 2000, 403 (6768) : 385-389.
  • 6Yu L, Harms PW, Pouryazdanparast P, et al. Expression of the embryonic morphogen Nodal in cutaneous melanocytic lesions [ J ]. Mod Pathol, 2010, 23 (9) : 1209-1214.
  • 7Chen MH, Yip GW, Tse GM, et al. Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters [ J]. Mod Pathol, 2008, 21 (10) : 1183-1191.
  • 8Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma [ J ]. N Engl J Med, 1991, 324 (1) : 1-8.
  • 9Jemal A, Bray F, Center MM, et al. Global cancer statistics [ J ]. CA Cancer J Clin, 2011,61 (2): 69-90.
  • 10吴孟超.我国肝切除技术发展的现状和展望[J].中华外科杂志,2010,48(3):161-162. 被引量:27

二级参考文献6

共引文献31

同被引文献33

  • 1Keangin K,Wessapan T, Rattanadecho P. Analysis of heat trans- fer in deformed liver cancer modeling treated using a microwave coaxial antenna[J]. Appl Therm Eng, 2011, 31:3243-3254.
  • 2Mast TD, Barthe PG, Makin IR, et al. Treatment of rabbit liver cancer in vivo using miniaturized image-ablate ultrasound arrays [ J]. Ultrasound Med Biol, 2011, 37 : 1609-1621.
  • 3Baran TM, Foster TH. Recovery of intrinsic fluorescence from single-point interstitial measurements for quantification of doxo- rubicin concentration [ J ]. Lasers Surg Med, 2013, 45: 542 -550.
  • 4Li D, Ding CY, Qiu LH. Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis[J]. Gynecol Oncol, 2015, 139(2): 355-362.
  • 5Yuan X, Wu H, Xu H, et al. Notch signaling: an emerging therapeutic target for cancer treatment[J]. Cancer Lett, 2015, 369(1):20-27.
  • 6Liu MX, Siu MK, Liu SS, et al. Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notchl signaling in ovarian cancer[J]. Oncotarget, 2014, 5(4):944-958.
  • 7Liu H, Zhang H, Shen Z, et al. Expression of Jaggedl predicts postoperative clinical outcome of patients with gastric cancer [J]. Int J Chn Exp Med, 2015, 8(9):14782-14792.
  • 8Takebe N, Miele L, Harris PJ, et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinicalupdate[J]. Nat Rev Clin Oneol, 2015, 12(8):445-464.
  • 9Wang M, Wu L, Wang L, et al. Down-regulation of Notchl by gamma-secretase inhibition contributes to cell growth inhibition and apoptosis in ovarian cancer cells A2780[J]. Biochem Biophys Res Commun, 2010, 393(1):144-149.
  • 10Ivan C, Hu W, Bottsford-Miller J, et al. Epigenetie analysis of the Notch superfamily in high-grade serous ovarian cancer[J]. Gynecol Oncol, 2013, 128(3):506-511.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部